Pear Therapeutics
Founded Year
2013Stage
Asset Sale | AssetsPurchasedTotal Raised
$334.94MAbout Pear Therapeutics
Pear Therapeutics discovers, develops, and delivers clinically-validated Prescription Digital Therapeutics to provide outcomes for patients, engagement and tracking tools for clinicians, and solutions for payers. The company was founded in 2013 and is based in Boston, Massachusetts.
Missing: Pear Therapeutics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Pear Therapeutics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Research containing Pear Therapeutics
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Pear Therapeutics in 5 CB Insights research briefs, most recently on Jan 24, 2023.
Expert Collections containing Pear Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Pear Therapeutics is included in 9 Expert Collections, including Mental Health Tech.
Mental Health Tech
1,285 items
This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.
Digital Health 150
300 items
2019's cohort of the most promising digital health startups transforming the healthcare industry
Sleep Health & Wellness
804 items
These companies aim to assess or improve the quantity/quality of sleep, or use sleep data in the monitoring or diagnosis of other health conditions.
Medical Devices
12,358 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Biopharma Tech
15,535 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Cancer
3,605 items
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.
Pear Therapeutics Patents
Pear Therapeutics has filed 13 patents.
The 3 most popular patent topics include:
- Psychiatric diagnosis
- Graphical user interface elements
- Cognitive behavioral therapy
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/15/2021 | 5/23/2023 | Data security, Computer security, Immunology, Data management, Medical specialties | Grant |
Application Date | 3/15/2021 |
|---|---|
Grant Date | 5/23/2023 |
Title | |
Related Topics | Data security, Computer security, Immunology, Data management, Medical specialties |
Status | Grant |
Latest Pear Therapeutics News
May 22, 2023
The potential sales price is a dramatic turn for the company, which went public in December 2021 through special purpose acquisition company Thimble Point Acquisition in a deal that valued it at $1.6 billion. Pear, which reported $13 million in revenue last year and lost around $123 million, filed for bankruptcy in April . In the Chapter 11 filing, it listed $65.6 million in assets and $51 million in debt. Pear developed solutions for opioid use disorder and insomnia, which were among the first digital therapeutics to receive clearance from the Food and Drug Administration. But it ran into challenges with payer reimbursement . Founder and CEO Corey McCann said in a LinkedIn post shortly after it filed for bankruptcy that the company had failed because of denials from payers and market conditions. According to court filings, Click Therapeutics, a digital therapeutics company, seeks to buy different patents from Pear for $70,000. Nox Health, a company that develops diagnostics for sleeping, wants to buy Pear’s insomnia therapeutics product for $3.9 million. Welt, a digital biomarkers company, plans to buy Pear’s migraine-related assets for $50,000. Harvest Bio seeks to acquire Pear’s substance use disorder therapeutic as well as various trademarks, licenses and patients for $2.03 million. Related Articles
Pear Therapeutics Frequently Asked Questions (FAQ)
When was Pear Therapeutics founded?
Pear Therapeutics was founded in 2013.
Where is Pear Therapeutics's headquarters?
Pear Therapeutics's headquarters is located at 200 State St, Boston.
What is Pear Therapeutics's latest funding round?
Pear Therapeutics's latest funding round is Asset Sale.
How much did Pear Therapeutics raise?
Pear Therapeutics raised a total of $334.94M.
Who are the investors of Pear Therapeutics?
Investors of Pear Therapeutics include Harvest Bio, WELT, Click Therapeutics, Nox Health, SoftBank and 17 more.
Who are Pear Therapeutics's competitors?
Competitors of Pear Therapeutics include BlueSignum, opiAID, Feel Therapeutics, metaMe Health, HelloBetter, GrayMatters Health, Twill, Amalgam Rx, WonderLab, Valera Health and 30 more.
Compare Pear Therapeutics to Competitors
Click Therapeutics develops and commercializes software as prescription medical treatments for people with unmet medical needs. It enables change within individuals and can be used independently or in conjunction with biomedical treatments. The company was founded in 2012 and is based in New York, New York.
Twill provides digital therapeutics and care delivery models focused on mental and physical health. It partners with enterprises, pharma companies, and health plans to create new products that help support and manage specific mental and physical conditions. The company was formerly known as Happify Health and Happify. It was founded in 2012 and is based in New York, New York.
GAIA develops digital therapy solutions that offer physicians, therapists, payers, and patients the same effect sizes, similar safety profiles, and equal levels of convenience as found in well-developed, pharmaceutical solutions. Its product lines include Velibra, a platform for excessive fears and worries; Elevida, an online program for people with MS fatigue; Deprexis, an online platform for people with depression; Vorvida, a tool to reduce alcohol consumption; Optimune, offering digital therapy for breast cancer; and Levidex, a companion for multiple sclerosis. The company was founded in 1997 and is based in Hamburg, Germany.
BrightInsight provides a digital health care solutions. The company provides digital health solutions for cardiovascular diseases, diabetes, immunology, oncology, and more. It was formerly known as Flex Digital Health. The company was founded in 2018 and is based in San Jose, California.
Ellipsis Health develops artificial intelligence (AI) generated vocal biomarker technology. It helps in identifying, assessing, and monitoring mental health with a short voice sample, its technology determines the severity of anxiety and depression. Ellipsis Health was founded in 2017 and is based in San Francisco, California.
Big Health develops a digital healthcare portal for mental health issues. It offers digital therapeutics services and automated behavioral programs. The company provides Sleepio for users in need of sleep issues. It was founded in 2010 and is based in San Francisco, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.